Bionano Genomics (BNGO) Other Accumulated Expenses (2024 - 2026)

Bionano Genomics (BNGO) has 3 years of Other Accumulated Expenses data on file, last reported at $458000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $458000.0; the trailing twelve-month figure through Mar 2026 stood at $458000.0 (changed N/A YoY), and the FY2025 full-year result was $502000.0, up 3037.5% from the prior year.
• Other Accumulated Expenses fell to $458000.0 in Q1 2026, from $502000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $502000.0 in Q4 2025 to a low of $16000.0 in Q4 2024.
• A 3-year average of $325333.3 and a median of $458000.0 in 2026 frame the typical range for Other Accumulated Expenses.
• Peak annual rise in Other Accumulated Expenses reached 3037.5% in 2025, while the deepest fall reached 3037.5% in 2025.
• Tracing BNGO's Other Accumulated Expenses over 3 years: stood at $16000.0 in 2024, then jumped by 3037.5% to $502000.0 in 2025, then fell by 8.76% to $458000.0 in 2026.
• Business Quant data shows BNGO's Other Accumulated Expenses at $458000.0 in Q1 2026, $502000.0 in Q4 2025, and $16000.0 in Q4 2024.